Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm

L. Koechlin, J. Boeddinghaus, P. Lopez-Ayala, T. Nestelberger, D. Wussler, F. Mais, R. Twerenbold, T. Zimmermann, K. Wildi, AM. Köppen, Ò. Miró, FJ. Martin-Sanchez, D. Kawecki, N. Geigy, DI. Keller, M. Christ, A. Buser, MR. Giménez, L....

. 2023 ; 255 (-) : 58-70. [pub] 20221013

Jazyk angličtina Země Spojené státy americké

Typ dokumentu multicentrická studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032061
E-zdroje Online Plný text

NLK ProQuest Central od 2002-01-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2002-01-01 do Před 2 měsíci
Health Management Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Public Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci

BACKGROUND: We aimed to assess the diagnostic utility of the Dimension EXL LOCI High-Sensitivity Troponin I (hs-cTnI-EXL) assay. METHODS: This multicenter study included patients with chest discomfort presenting to the emergency department. Diagnoses were centrally and independently adjudicated by two cardiologists using all available clinical information. Adjudication was performed twice including serial measurements of high-sensitivity cardiac troponin (hs-cTn) I-Architect (primary analysis) and serial measurements of hs-cTnT-Elecsys (secondary analysis) in addition to the clinically used (hs)-cTn. The primary objective was to assess and compare the discriminatory performance of hs-cTnI-EXL, hs-cTnI-Architect and hs-cTnT-Elecsys for acute myocardial infarction (MI). Furthermore, we derived and validated a hs-cTnI-EXL-specific 0/1h-algorithm. RESULTS: Adjudicated MI was the diagnosis in 204/1454 (14%) patients. The area under the receiver operating characteristics curve for hs-cTnI-EXL was 0.94 (95%CI, 0.93-0.96), and comparable to hs-cTnI-Architect (0.95; 95%CI, 0.93-0.96) and hs-cTnT-Elecsys (0.93; 95%CI, 0.91-0.95). In the derivation cohort (n = 813), optimal criteria for rule-out of MI were <9ng/L at presentation (if chest pain onset >3h) or <9ng/L and 0h-1h-change <5ng/L, and for rule-in ≥160ng/L at presentation or 0h-1h-change ≥100ng/L. In the validation cohort (n = 345), these cut-offs ruled-out 56% of patients (negative predictive value 99.5% (95%CI, 97.1-99.9), sensitivity 97.8% (95%CI, 88.7-99.6)), and ruled-in 9% (positive predictive value 83.3% (95%CI, 66.4-92.7), specificity 98.3% (95%CI, 96.1-99.3)). Secondary analyses using adjudication based on hs-cTnT measurements confirmed the findings. CONCLUSIONS: The overall performance of the hs-cTnI-EXL was comparable to best-validated hs-cTnT/I assays and an assay-specific 0/1h-algorithm safely rules out and accurately rules in acute MI. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov number, NCT00470587.

2nd Department of Cardiology School of Medicine with the Division of Dentistry in Zabrze Medical University of Katowice Silesian Poland

BHF University Centre for Cardiovascular Science University of Edinburgh Edinburgh UK

Cardiovascular Research Institute Basel and Department of Cardiology University Hospital Basel University of Basel Basel Basel Switzerland

Critical Care Research Group and the University of Queensland Brisbane Queensland Australia

Department of Cardiac Surgery University Hospital Basel University of Basel Basel Basel Switzerland

Department of Cardiology Heart Center Leipzig University of Leipzig Leipzig Saxony Germany

Department of hematology and Blood Bank University Hospital Basel University of Basel Basel Basel Switzerland

Division of Cardiology Vancouver General Hospital University of British Columbia Vancouver British Columbia Canada

Division of Internal Medicine University Hospital Basel University of Basel Basel Basel Switzerland

Emergency Department Hospital Clinic Barcelona Catalonia Spain

Emergency Department Kantonsspital Liestal Liestal Liestal Switzerland

Emergency Department Kantonsspital Luzern Luzern Luzern Switzerland

Emergency Department University Hospital Zurich Zurich Zurich Switzerland

GREAT network Basel Basel Switzerland

Institute of Laboratory Medicine County Hospital Aarau Aarau Aarau Switzerland

Servicio de Urgencias Hospital Clínico San Carlos Madrid Madrid Spain

University Center of Cardiovascular Science and Department of Cardiology University Heart and Vascular Center Hamburg University Medical Center Hamburg Eppendorf Hamburg Hamburg Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032061
003      
CZ-PrNML
005      
20230131150657.0
007      
ta
008      
230120s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ahj.2022.10.007 $2 doi
035    __
$a (PubMed)36243111
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Koechlin, Luca $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; Department of Cardiac Surgery, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland. Electronic address: luca.koechlin@usb.ch
245    10
$a Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm / $c L. Koechlin, J. Boeddinghaus, P. Lopez-Ayala, T. Nestelberger, D. Wussler, F. Mais, R. Twerenbold, T. Zimmermann, K. Wildi, AM. Köppen, Ò. Miró, FJ. Martin-Sanchez, D. Kawecki, N. Geigy, DI. Keller, M. Christ, A. Buser, MR. Giménez, L. Bernasconi, A. Hammerer-Lercher, C. Mueller, APACE investigators
520    9_
$a BACKGROUND: We aimed to assess the diagnostic utility of the Dimension EXL LOCI High-Sensitivity Troponin I (hs-cTnI-EXL) assay. METHODS: This multicenter study included patients with chest discomfort presenting to the emergency department. Diagnoses were centrally and independently adjudicated by two cardiologists using all available clinical information. Adjudication was performed twice including serial measurements of high-sensitivity cardiac troponin (hs-cTn) I-Architect (primary analysis) and serial measurements of hs-cTnT-Elecsys (secondary analysis) in addition to the clinically used (hs)-cTn. The primary objective was to assess and compare the discriminatory performance of hs-cTnI-EXL, hs-cTnI-Architect and hs-cTnT-Elecsys for acute myocardial infarction (MI). Furthermore, we derived and validated a hs-cTnI-EXL-specific 0/1h-algorithm. RESULTS: Adjudicated MI was the diagnosis in 204/1454 (14%) patients. The area under the receiver operating characteristics curve for hs-cTnI-EXL was 0.94 (95%CI, 0.93-0.96), and comparable to hs-cTnI-Architect (0.95; 95%CI, 0.93-0.96) and hs-cTnT-Elecsys (0.93; 95%CI, 0.91-0.95). In the derivation cohort (n = 813), optimal criteria for rule-out of MI were <9ng/L at presentation (if chest pain onset >3h) or <9ng/L and 0h-1h-change <5ng/L, and for rule-in ≥160ng/L at presentation or 0h-1h-change ≥100ng/L. In the validation cohort (n = 345), these cut-offs ruled-out 56% of patients (negative predictive value 99.5% (95%CI, 97.1-99.9), sensitivity 97.8% (95%CI, 88.7-99.6)), and ruled-in 9% (positive predictive value 83.3% (95%CI, 66.4-92.7), specificity 98.3% (95%CI, 96.1-99.3)). Secondary analyses using adjudication based on hs-cTnT measurements confirmed the findings. CONCLUSIONS: The overall performance of the hs-cTnI-EXL was comparable to best-validated hs-cTnT/I assays and an assay-specific 0/1h-algorithm safely rules out and accurately rules in acute MI. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov number, NCT00470587.
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
650    _2
$a biologické markery $7 D015415
650    12
$a troponin I $7 D019210
650    _2
$a ROC křivka $7 D012372
650    12
$a infarkt myokardu $x diagnóza $7 D009203
650    _2
$a troponin T $7 D020107
655    _2
$a multicentrická studie $7 D016448
655    _2
$a časopisecké články $7 D016428
700    1_
$a Boeddinghaus, Jasper $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland; Division of Internal Medicine, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; BHF/University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
700    1_
$a Lopez-Ayala, Pedro $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland
700    1_
$a Nestelberger, Thomas $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland; Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
700    1_
$a Wussler, Desiree $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland; Division of Internal Medicine, University Hospital Basel, University of Basel, Basel, Basel, Switzerland
700    1_
$a Mais, Felix $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; Emergency Department, University Hospital Zurich, Zurich, Zurich, Switzerland
700    1_
$a Twerenbold, Raphael $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; University Center of Cardiovascular Science & Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
700    1_
$a Zimmermann, Tobias $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland
700    1_
$a Wildi, Karin $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland; Critical Care Research Group and the University of Queensland, Brisbane, Queensland, Australia
700    1_
$a Köppen, Anne Marie $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland
700    1_
$a Miró, Òscar $u GREAT network, Basel, Basel, Switzerland; Emergency Department, Hospital Clinic, Barcelona, Catalonia, Spain
700    1_
$a Martin-Sanchez, F Javier $u GREAT network, Basel, Basel, Switzerland; Servicio de Urgencias, Hospital Clínico San Carlos, Madrid, Madrid, Spain
700    1_
$a Kawecki, Damian $u GREAT network, Basel, Basel, Switzerland; 2nd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Katowice, Silesian, Poland
700    1_
$a Geigy, Nicolas $u Emergency Department, Kantonsspital Liestal, Liestal Liestal, Switzerland
700    1_
$a Keller, Dagmar I $u Emergency Department, University Hospital Zurich, Zurich, Zurich, Switzerland
700    1_
$a Christ, Michael $u Emergency Department, Kantonsspital Luzern, Luzern, Luzern, Switzerland
700    1_
$a Buser, Andreas $u Department of hematology and Blood Bank, University Hospital Basel, University of Basel, Basel, Basel Switzerland
700    1_
$a Giménez, Maria Rubini $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; Department of Cardiology, Heart Center Leipzig, University of Leipzig, Leipzig, Saxony, Germany
700    1_
$a Bernasconi, Luca $u Institute of Laboratory Medicine, County Hospital Aarau, Aarau, Aarau, Switzerland
700    1_
$a Hammerer-Lercher, Angelika $u Institute of Laboratory Medicine, County Hospital Aarau, Aarau, Aarau, Switzerland
700    1_
$a Mueller, Christian $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Basel, Switzerland; GREAT network, Basel, Basel, Switzerland. Electronic address: christian.mueller@usb.ch
710    2_
$a APACE investigators
773    0_
$w MED00000228 $t American heart journal $x 1097-6744 $g Roč. 255, č. - (2023), s. 58-70
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36243111 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131150653 $b ABA008
999    __
$a ok $b bmc $g 1891062 $s 1183396
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 255 $c - $d 58-70 $e 20221013 $i 1097-6744 $m The American heart journal $n Am Heart J $x MED00000228
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...